Bonstein Sara's Form 4 filing
INSMED Inc (INSM) · filed Jan 10, 2025
- Accession no.
- 0001628280-25-001206
- Filed
- Jan 10, 2025
- Trade date
- Jan 7-10, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $392.6K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bonstein SaraCIK 0001604019 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 7, 2025 | Common Stock | SSaleDisposed | −3,470 | $65.70F2 | −$227,979 | 114,736 | Direct | |
| Jan 8, 2025 | Common Stock | SSaleDisposed | −1,464 | $66.05 | −$96,697.2 | 113,272 | Direct | |
| Jan 8, 2025 | Common Stock | AGrant or awardAcquired | +6,657 | –F5 | – | 119,929 | Direct | |
| Jan 10, 2025 | Common Stock | SSaleDisposed | −1,066 | $63.72 | −$67,925.52 | 118,863 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 8, 2025 | Common Stock | AGrant or awardAcquired | +31,930 | $0.00 | $0 | 31,930 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This is the weighted average sales price representing 3,470 shares sold at prices ranging from $65.69 to $65.72 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F5
Each RSU was granted on January 8, 2025 for no consideration.
Referenced by the price of 1 transaction in Table I.